血管内动脉栓塞与保守的管理与鼻包装单独严重的表:一个全国性的队列研究
Huanwen Chen1,2, Mihir Khunte3, Marco Colasurdo4
1Neurointerventional Surgery, University of Maryland Medical Center, Baltimore, Maryland, USA.
Journal of neurointerventional surgery
|December 23, 2024
概括
与单独的鼻包装相比,内血管动脉栓塞 (EAE) 显著降低了严重表复发和患者的发病率. 然而,EAE与缺血性中风风险的小但显著增加有关.
科学领域:
- 血管外科 血管外科
- 干预性放射学 干预性放射学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 严重的表观症往往需要比保守的鼻包装外的干预措施.
- 现实世界的数据比较血管内动脉栓塞 (EAE) 与单独用于表的鼻包装是有限的.
研究的目的:
- 为了比较EAE的有效性和安全性与单独用于严重表症的鼻包装.
- 评估结果,包括表复发,医院出院状态和缺血性中风风险.
主要方法:
- 使用全国再接收数据库 (2016-2021) 进行回顾性队列研究.
- 包括患有严重表症的患者,仅用鼻包装或EAE治疗.
- 使用倾向分数匹配 (PSM) 来平衡患者的特征.
主要成果:
- EAE与显著降低表性再入院风险相关 (4.6%与10.6%相比).
- 经过EAE,非例行性出院率较低 (22.1%与28.9%相比).
- 与EAE (1.6%与0.4%) 观察到较高的缺血性中风率.
结论:
- 血管内动脉栓塞 (EAE) 是严重表症的有效治疗方法,与鼻包装相比,减少了复发和发病率.
- 虽然EAE提供了显著的好处,但缺血性中风的风险增加值得考虑.
更多相关视频
相关概念视频
Epistaxis
127
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
127
Esophageal Varices-II: Clinical Features and Management
46
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
46
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
135
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
135


